JPRN-jRCT1092220318
Completed
未知
A clinical trial in patients with malignancies where the spaces formed by the KHKA-01 are needed in performing particle radiation therapy. - KHKA-01-01
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Alfresa Pharma Corporation
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients who were diagnosed with malignancies by diagnostic imaging or by histological diagnosis
- •(2\) Patients with malignancies which were localized and without other sites of disease (distant disease)
- •(3\) Patients with malignancies where the KHKA\-01 can be surgically placed in the space between the margin of malignancies and normal tissues
- •(4\) Patients with performance status of 0, 1, and 2
- •(5\) Patients who can maintain posture (the supine position for about 30 minutes)
- •(6\) Patients who can write consent of the patient about participation of this trial
Exclusion Criteria
- •1\) Patients meeting any of the following exclusion criteria on the initial visit day are excluded from study participation
- •(1\) Patients with a history of radiation therapy to these malignancies or who are planned to undergo additional radiation therapy to the same site as in this study from 28 days prior to surgery to the end of observation at Week 4 after the end of radiation
- •(2\) Patients with active and refractory infection at the radiation site
- •(3\) Patients with active double cancer
- •(4\) Patients with peptic ulcer in the planned irradiated volume
- •(5\) Patients with life expectancy of less than 12 months on the initial visit day
- •(6\) Patients on chemotherapy, immunotherapy and others or who are planned to undergo chemotherapy, immunotherapy, surgery, ablation treatment, and others from 28 days prior to surgery to the end of observation at Week 4 after the end of radiation
- •(7\) Patients with serious hepatic and renal dysfunction (about grade 2 of classification of the severity of adverse drug reactions) However, the exclusion criteria are not applied if the malignancies in this study affect the liver or kidney
- •(8\) Patients with mental disorder who cannot follow the protocol, patients with alcoholism and patients with drug dependence
- •(9\) Women who are pregnant or may be pregnant, women who are breastfeeding, women in disagree with birth control during clinical trial period
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Improving access to psychological services for people with cancer: A randomised controlled trial of an interactive web-based intervention (CancerCope)ACTRN12613001026718Griffith University490
Active, not recruiting
Phase 1
Clinical trial with chemotherapy for patients with non-resectable locally advanced pancreatic cancer and addition of chemo-radiotherapy for patients with borderline resectable pancreatic cancer. DPSG - ”Danish Pancreatic cancer Study Group”EUCTR2011-000703-40-DKOdense University Hospital53
Completed
Not Applicable
Cancer Research Campaign trial for the treatment of women with early breast cancer: the role of local prophylactic radiotherapyBreastCancerISRCTN65764657Cancer Research UK (CRUK) (UK)
Recruiting
Not Applicable
Clinical trial on the availability of tumor sites marking using indocyanine green in Laparoscopic Surgery of Colon CancerColorectal cancerJPRN-UMIN000033982Sapporo Medical University School of Medicine Department of Surgery, Surgical Oncology and Science100
Active, not recruiting
Not Applicable
Assessment of therapeutic equivalence, tolerability and patients satisfaction in subjects affected of neck pain treated with medicated plasters containing piroxicam or diclofenac.cervical pain of osteoarthritic originMedDRA version: 14.1Level: LLTClassification code 10008322Term: CervicalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2011-000023-33-ITS.P.A. ITALIANA LABORATORI BOUTY